Santhera Pharmaceuticals (Switzerland) AG

Swiss Biotech Association

Member

Santhera Pharmaceuticals (SIX: SANN) is a Swiss specialty pharmaceutical company focused on the development and commercialization of innovative medicines for rare neuromuscular and pulmonary diseases with high unmet medical need.

http://www.santhera.com
+41 61 906 89 50
eva.kalias@santhera.com
Eva Kalias

Location

Hohenrainstrasse 24, 4133 Pratteln, Switzerland

Get Directions

Facts & figures

Type of organization

Public company
Year of foundation

2004
Number of employees in Switzerland

50-149

Key business

Core competencies

Therapeutics/vaccines (human)

You may also be interested in

Praed Pharmaceuticals Ltd

Praed Pharmaceuticals is biopharmaceutical company founded by industry experts. Our mission is to deliver a next generation treatment for Crohn’s disease. We are developing a promising oral compound, cadazolid, for the treatment of Crohn’s disease.
4054 Basel

Member

Philip Morris International

https://www.pmi.com/our-transformation
2000 Neuchâtel

Member

Ymmunobio AG

Ymmunobio AG is a preclinical stage biotechnology company developing a novel class of immune oncology therapeutic antibodies. The proprietary CEACAM1 antibodies are having a direct co-stimulatory effect on immune cells in addition to interfering with the CEACAM1-CEACAM mediated check-point blockade.
4125 Riehen

Member